1.     Phase III ASAP trial

https://ash.confex.com/ash/2022/webprogram/Paper159962.html

2.     Phase III Dauno-Double Trial

https://ash.confex.com/ash/2022/webprogram/Paper157126.html

3.     Reduced venetoclax exposure: 

https://ash.confex.com/ash/2022/webprogram/Paper165464.html

4.    Menin Inhibitors in AML 

https://ash.confex.com/ash/2022/webprogram/Paper164849.html

https://ash.confex.com/ash/2022/webprogram/Paper167412.html

5.    Imetelstat in MDS: IMerge Phase 2

https://ash.confex.com/ash/2022/webprogram/Paper169050.html

6.    MOMENTUM: Momelotinib

https://ash.confex.com/ash/2022/webprogram/Paper162783.html

How I manage anemia related to myelofibrosis and its treatment regimens

 https://link.springer.com/article/10.1007/s00277-023-05126-4